Register on pregnancies in inflammatory rheumatic diseases Rhekiss (Rheumatism, child wish and pregnancy)

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00024215

Enrollment

3000

Registered

2021-06-09

Start date

2015-09-01

Completion date

Unknown

Last updated

2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Inflammatory-rheumatic diseases O00-O99 Z30-Z39

Interventions

Group 1: There are no interventions. The study is an observational cohort study. Online questionnaires on health status and current therapy are completed at set times (every six months until pregnancy

Eligibility

Sex/Gender

Female

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients with inflammatory rheumatic disease, with child wish or at the beginning of pregnancy (up to 20 weeks gestation).

Exclusion criteria

Exclusion criteria: Pregnancy after 20 th week of gestation

Design outcomes

Primary

Measure	Time frame
Knowledge gain about the course of pregnancies in women with inflammatory rheumatic diseases and the development of children in the first two years of life.	—

Secondary

Measure	Time frame
Rhekiss is intended to increase safety in the care of affected women - in the future it should be easier to advise patients on the basis of reliable data.	—

Countries

Germany

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Jun 11, 2026